Xconomy

DECEMBER 26, 2018

The sector saw more big venture capital deals and acquisitions , while researchers kept plugging away on technology advances. software startups to reflect on the trends that defined the sector in 2018—and where things might be headed in 2019. It was an eventful year for the artificial intelligence industry.

Artificial Inteligence 94

Artificial Inteligence Venture Capital Research Acquisition 94

Xconomy

APRIL 9, 2018

Venture capital investors poured more than $28.2 companies during the first three months of 2018—marking the strongest single quarter in at least a dozen years, according to the Venture Monitor Report released today by Seattle-based PitchBook and the National Venture Capital Association (NVCA).

Venture Capital 74

Venture Capital Funding Capital Report 74

Both Sides of the Table

MARCH 23, 2015

My goal in the interview overall was to capture more of the personal side of Fred since so much of his investment thesis and portfolio work already comes out in his blog. We talk a lot about his schooling, his early jobs as a developer and then as a VC and we talk about his decision to spend winters in Los Angeles.

Venture Capital 150

Venture Capital Startup Writing Blogging 150

Xconomy

OCTOBER 17, 2019

Atomico, a European venture capital firm, has helped persuade Cambridge, UK-based Healx to return to the capital market a year earlier than anticipated. It is not surprising that venture capitalists have been knocking on the door at Healx. Read more » Reprints | Share:

Artificial Inteligence 52

Artificial Inteligence Venture Capital Platform Capital 52

Xconomy

MARCH 11, 2019

She succeeds Greg McKee, who served as president and CEO of the San Diego-based organization for five years before stepping down last month to start a venture capital fund. She’s also a partner in Ad Astra Ventures, an accelerator and venture fund for women-led startups she started in 2018 with Allison Long Pettine and Vidya Dinamani.

San Diego 67

San Diego Venture Capital Organization Entrepreneur 67

Xconomy

APRIL 9, 2018

View the Slideshow With the first quarter in the books, it’s time to step back and lay out Xconomy’s editorial map for the rest of the year.

News 86

News Education Conference Report 86

Xconomy

MAY 26, 2020

Privately held biotech ViaCyte has banked $27 million, the majority an installment of cash from a tranched $80 million Series D financing round it closed in late 2018.

Help 131

Help Develop Development San Diego 131

Both Sides of the Table

AUGUST 20, 2015

VC funding. We love capital efficiency until we love land grabs until we abhor over funding until we get huge payouts and ring the bell for more funding until we attract every non-VC on the planet to invest in startups until it crashes and we start the cycle all over again none the wiser. blog here ). April 30th, 2018.

Funding 150

Funding Venture Capital Startup Marketing 150

Xconomy

JULY 24, 2018

This fall, we are convening exemplary business leaders, investors, and far-seeing technologists for an in-depth exploration of the innovation ecosystem and its impact on the future. Come join us at our newest interactive conference, XCON: The Xconomy Conference on Technology and Transformation.

Conference 49

Conference Technology Google Sites 49

Xconomy

OCTOBER 19, 2017

From Portland to Pittsburgh, it’s likely that every city in the U.S. with more than 1 million people has made its case to Amazon to locate the company’s second headquarters there. At least, hopefully they have already, because today—if you haven’t heard—was the deadline to apply.

Develop 82

Develop Development Software Development San Diego 82

Xconomy

JANUARY 9, 2018

René Pinnell says he and his wife Selena Pinnell were “blown away” by the virtual reality projects their friends were creating in 2014, so they looked for an entrepreneurial niche that would allow them to support such artists. That year the couple, both trained in design, founded a startup in San Francisco, then called KaleidoscopeVR.

Content 71

Content Training Design Startup 71

Xconomy

APRIL 27, 2020

On Monday Erasca—a portmanteau of “erase” and “cancer”— announced it had completed a Series B financing round jointly led by Arch Venture Partners and Cormorant Asset Management. The San Diego-based biotech, which started operations about 18 months ago, made its public debut in December 2018 with $42 million.

San Diego 76

San Diego Entrepreneur Develop Development 76

Xconomy

JULY 19, 2019

But when the financial oversight council published its 2018 annual report, it concluded that volatility in the cryptocurrency. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 89

Pricing Report Invest Venture Capital 89

Xconomy

APRIL 23, 2019

After a breakout year in 2017, the blockchain sector suffered a series of blows in 2018, from crashing cryptocurrency prices to increased regulatory scrutiny of crypto ventures and deepening skepticism about whether the technology was actually useful.

Report 98

Report Pricing Organization Technology 98

Xconomy

JANUARY 4, 2019

In 2018, geopolitical events—in particular, President Donald Trump’s hard-line stances on trade and immigration, and the repeal of net neutrality rules—were top of mind for several business executives we interviewed recently.

San Diego 102

San Diego .Net Startup Develop 102

Xconomy

JANUARY 24, 2019

million in seed—in 2018 to advance its growing suite of products, digitized. The team at Trust & Will, a San Diego-based startup founded in October of 2017, is betting that a good chunk of those people would shell out some money to outline an estate plan if the process were cheaper and easier.

San Diego 73

San Diego Seed Funding Funding Startup 73

TechCrunch LA

NOVEMBER 4, 2019

First it was street-style photography, then came the launch of her popular fashion blog WeWoreWhat. Another company, Tribe , has similarly raised VC to grow its American footprint. The firm even launched an accelerator for YouTube personalities in late 2018. With new followers — today her account, @weworewhat , has 2.2

Platform 170

Platform Marketing Tool Venture Capital 170

Xconomy

JANUARY 4, 2019

In 2018, my Exome colleagues and I published hundreds of stories about health, medicine, the biopharma industry, government policy, and more. You’ll find a few of our favorite stories in this review of some of the year’s best from across the Xconomy network.

Pricing 69

Pricing Email Networking Silver Lake 69

Xconomy

JANUARY 15, 2019

As Xconomy’s editors looked back at the year just passed, we asked technology leaders to comment on the trends they’d observed in 2018, and the developments they expected in 2019.

.Net 65

.Net Technology Develop Development 65

Xconomy

JANUARY 8, 2019

When we have a chance to view it from a distance, the year 2018 may be seen as a period when innovations in a number of technological fields came together to transform not only the future of computing, but also the very structure of the Internet.

Artificial Inteligence 62

Artificial Inteligence Demand Software Development Software 62

Xconomy

DECEMBER 28, 2017

Xconomy: If you think public perception about the tech industry turned for the worse in 2017, what should the industry do to rebuild trust in 2018? (Palmer previously co-founded Vertica Systems, now part of HP.) Andy Palmer: I think that increased awareness of gender equity issues. Read more » Reprints | Share:

Equity 87

Equity Software Networking Entrepreneur 87

Xconomy

AUGUST 16, 2019

billion in 2018, and Novartis reportedly knew but failed to report it to the FDA before the agency approved Zolgensma in May. We learned last week that the FDA was investigating Novartis for manipulating animal data related to its $2 million-a-dose gene therapy Zolgensma. The activity took place at AveXis, the firm Novartis bought for $8.7

Report 63

Report Activity San Diego Study 63

Xconomy

SEPTEMBER 7, 2017

Amazon will pick the city in 2018. Amazon sent cities across North America into a frenzy Thursday after announcing plans to build a second headquarters outside of Seattle, bringing with it tens of thousands of jobs and billions of dollars in economic development benefits. Mexico is also part.

Commerce 76

Commerce Develop Development Software Development 76

Xconomy

MARCH 2, 2018

The money came from a wide range of backers, not just traditional biotech venture firms. It’s early yet in 2018, but the current count could put life-sciences companies on pace to bust past last year’s $17.6 billion, a figure compiled in the Venture Monitor Report. Elsewhere, the U.S.

Funding 52

Funding Report Startup Venture Capital 52

Tech.Co

NOVEMBER 29, 2017

Station F is led by Roxanne Varza , who’s been very actively supporting startups and the French startup ecosystem as former head of Microsoft Accelerator in France, cofounder of European blog Tech.eu. Amongst its tenants are over 10 VC funds who have taken desks on Campus: Accel, Index Ventures, Balderton, Daphni, Partech Ventures.

Startup 70

Startup Google Venture Capital Outsource Development 70

Xconomy

DECEMBER 8, 2017

With 2018 around the corner, this was a week to look ahead. At Xconomy, we zeroed in on several clinical trials that could become major stories in the life sciences. Other healthcare milestones are on the way, too. The FDA will consider for the first time whether a video game should be approved as medicine.

Course 66

Course San Diego Journal Company 66

Xconomy

JANUARY 10, 2019

Yet in 2018, perceptions about these dominant companies often reflected uneasiness and doubt—and for some, so did their stock performance. The market caps of some of the most successful tech titans reach as high as $1 trillion.

Platform 43

Platform Marketing Company Companies 43

Xconomy

DECEMBER 7, 2017

Proceeds will be used to advance Metacrine’s lead drug candidate, MET409, into first-in-human studies during the first half of 2018. Initial studies should be completed by the end of the year, the San Diego-based company said.

San Diego 49

San Diego Study Develop Development 49

Xconomy

FEBRUARY 9, 2018

The top biopharma story of the week involves the fast-moving field of lung cancer, which, as we’ve written previously, has several key trials reading out in 2018. A big domino fell this week: data from a two-drug immunotherapy combination developed by Bristol-Myers Squibb. But the results, touted as positive, left more questions than answers.

Help 58

Help Develop Development Arcturus 58